S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut

Myriad Genetics (MYGN) SEC Filings & 10K Form

$18.51
-0.13 (-0.70%)
(As of 04/18/2024 ET)

Recent Myriad Genetics SEC Filings

DateFilerForm TypeView
04/17/2024
3:31 PM
Myriad Genetics (Filer)
Form DEF 14A
04/17/2024
3:31 PM
Myriad Genetics (Filer)
Form DEFA14A
04/17/2024
3:33 PM
Myriad Genetics (Filer)
Form ARS
04/15/2024
3:25 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:49 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:39 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Myriad Genetics (Subject)
Form SC 13G
03/04/2024
3:18 PM
Myriad Genetics (Issuer)
Solaiman Shereen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:31 AM
Myriad Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
7:24 AM
Camber Capital Management LP (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/29/2024
3:21 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2024
3:27 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
12:20 PM
Myriad Genetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
3:31 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/16/2024
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
4:52 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
7:30 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
5:34 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:41 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:19 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:31 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
5:02 AM
Myriad Genetics (Filer)
Form 424B5
11/08/2023
8:16 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
7:30 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:05 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:12 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
8:00 PM
Myriad Genetics (Subject)
Riggsbee Richard Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
3:34 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
3:17 PM
Myriad Genetics (Issuer)
Wong Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:14 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Myriad Genetics (Subject)
Form SC 13G
10/11/2023
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
3:15 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:17 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:19 PM
Lambert Nicole (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:21 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:22 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
7:30 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
3:30 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:32 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.
09/27/2023
3:18 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:21 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:27 PM
Lambert Nicole (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:26 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:31 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:33 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
7:24 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
5:20 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:21 PM
BISARO PAUL (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:00 PM
Myriad Genetics (Issuer)
Phanstiel S. Louise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:05 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:07 PM
Myriad Genetics (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:11 PM
Myriad Genetics (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:15 PM
Myriad Genetics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:17 PM
Myriad Genetics (Issuer)
Skovronsky Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
3:31 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
9:26 AM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MYGN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners